G.D. Sweeney

1.7k total citations
49 papers, 1.4k citations indexed

About

G.D. Sweeney is a scholar working on Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, G.D. Sweeney has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Pharmacology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in G.D. Sweeney's work include Porphyrin Metabolism and Disorders (11 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Neonatal Health and Biochemistry (8 papers). G.D. Sweeney is often cited by papers focused on Porphyrin Metabolism and Disorders (11 papers), Pharmacogenetics and Drug Metabolism (10 papers) and Neonatal Health and Biochemistry (8 papers). G.D. Sweeney collaborates with scholars based in Canada, United Kingdom and South Africa. G.D. Sweeney's co-authors include Jack Gauldie, K.G. Jones, John Goddard, E. Regoeczi, David A. Clark, Aleksander Koj, Daniel N. Sauder, Ross Cameron, Emmanuel Farber and Ken Jones and has published in prestigious journals such as The Lancet, Blood and Biochemical Journal.

In The Last Decade

G.D. Sweeney

48 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.D. Sweeney Canada 21 484 308 248 205 204 49 1.4k
Mary Treinen Moslen United States 20 363 0.8× 141 0.5× 273 1.1× 331 1.6× 69 0.3× 59 1.1k
Mostafa Z. Badr United States 21 644 1.3× 244 0.8× 219 0.9× 113 0.6× 78 0.4× 66 1.4k
Carl L. Alden United States 22 397 0.8× 276 0.9× 441 1.8× 180 0.9× 107 0.5× 65 1.4k
R R Miller United States 20 268 0.6× 366 1.2× 507 2.0× 252 1.2× 79 0.4× 38 1.5k
David R. Plowchalk United States 20 270 0.6× 195 0.6× 149 0.6× 330 1.6× 109 0.5× 27 1.4k
Bhupendra S. Kaphalia United States 24 497 1.0× 229 0.7× 172 0.7× 108 0.5× 225 1.1× 94 1.8k
T.C. Orton United Kingdom 16 633 1.3× 205 0.7× 271 1.1× 292 1.4× 47 0.2× 40 1.4k
Μartine Aggerbeck France 25 679 1.4× 238 0.8× 124 0.5× 156 0.8× 68 0.3× 59 1.6k
M. Firoze Khan United States 29 816 1.7× 256 0.8× 350 1.4× 131 0.6× 601 2.9× 91 2.1k
Rekha Mehta Canada 24 482 1.0× 224 0.7× 170 0.7× 83 0.4× 34 0.2× 54 1.5k

Countries citing papers authored by G.D. Sweeney

Since Specialization
Citations

This map shows the geographic impact of G.D. Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.D. Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.D. Sweeney more than expected).

Fields of papers citing papers by G.D. Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.D. Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.D. Sweeney. The network helps show where G.D. Sweeney may publish in the future.

Co-authorship network of co-authors of G.D. Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of G.D. Sweeney. A scholar is included among the top collaborators of G.D. Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.D. Sweeney. G.D. Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sweeney, G.D., Anne Holbrook, Marc Levine, et al.. (1990). Pharmacokinetics of carbetocin, a long-acting oxytocin analogue, in nonpregnant women. Current Therapeutic Research. 47(3). 528–540. 64 indexed citations
3.
Sweeney, G.D.. (1990). Clinical Pharmacology: A Conceptual Approach. 1 indexed citations
4.
Sweeney, G.D. & S Macleod. (1989). Anti-Allergy and Anti-Asthma Drugs. Clinical Pharmacokinetics. 17(Supplement 1). 156–168. 2 indexed citations
5.
Grace, E, Jack Rosenfeld, G.D. Sweeney, & W. Watson Buchanan. (1987). The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis. Current Medical Research and Opinion. 10(9). 580–591. 4 indexed citations
6.
Goddard, John & G.D. Sweeney. (1987). Delayed, ferrous iron-dependent peroxidation of rat liver microsomes. Archives of Biochemistry and Biophysics. 259(2). 372–381. 28 indexed citations
7.
Koj, Aleksander, Jack Gauldie, G.D. Sweeney, E. Regoeczi, & Daniel N. Sauder. (1985). A simple bioassay for monocyte-derived hepatocyte stimulating factor: Increased synthesis of α2-macroglobulin and reduced synthesis of albumin by cultured rat hepatocytes. Journal of Immunological Methods. 76(2). 317–327. 30 indexed citations
8.
Sweeney, G.D.. (1985). Experimental porphyria. Clinics in Dermatology. 3(2). 125–143. 2 indexed citations
9.
Sweeney, G.D., et al.. (1984). Release of ferrous iron from ferritin by liver microsomes: a possible role in the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Canadian Journal of Biochemistry and Cell Biology. 62(12). 1293–1300. 28 indexed citations
10.
Sweeney, G.D.. (1983). Variability in the human drug response. Thrombosis Research. 29. 3–15. 21 indexed citations
11.
Clark, David A., et al.. (1983). Cellular and genetic basis for suppression of cytotoxic T cell generation by haloaromatic hydrocarbons. Immunopharmacology. 6(2). 143–153. 110 indexed citations
12.
Goddard, John & G.D. Sweeney. (1983). Ferric nitrilotriacetate: A potent stimulant of lipid peroxidation in mice. Biochemical Pharmacology. 32(24). 3879–3882. 38 indexed citations
13.
Jones, K.G., et al.. (1981). The role of iron in the toxicity of 2,3,7,8-tetrachlorodibenzo-(p)-dioxin (TCDD). Toxicology and Applied Pharmacology. 61(1). 74–88. 44 indexed citations
14.
Sweeney, G.D.. (1981). Drugs???some basic concepts. Medicine & Science in Sports & Exercise. 13(4). 247–251. 22 indexed citations
15.
Jones, K.G. & G.D. Sweeney. (1979). Quantitation of urinary porphyrins by use of second-derivative spectroscopy.. Clinical Chemistry. 25(1). 71–74. 36 indexed citations
16.
Ingram, David, C. J. Dickinson, L. Saunders, et al.. (1979). Application of a pharmacokinetic simulation program in pharmacy courses. Computers & Education. 3(4). 335–345. 8 indexed citations
17.
Dickinson, C. J., David Ingram, Khursheed Ahmed, et al.. (1979). The Mac Family of Physiological Models. Alternatives to Laboratory Animals. 7(2_suppl). 52–59. 1 indexed citations
18.
Cameron, Ross, G.D. Sweeney, Ken Jones, George Lee, & Emmanuel Farber. (1976). A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(11 Pt 1). 3888–93. 108 indexed citations
19.
Lui, Henry & G.D. Sweeney. (1975). Hepatic metabolism of hexachlorobenzene in rats. FEBS Letters. 51(1-2). 225–226. 37 indexed citations
20.
Sweeney, G.D., et al.. (1973). Evidence against a regulatory role for heme oxygenase in hepatic heme synthesis. Biochimica et Biophysica Acta (BBA) - General Subjects. 304(3). 871–874. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026